Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

DiaMedica Therapeutics Q2 EPS $(0.13) Beats $(0.18) Estimate

DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.18) by 27.78 percent. This is a 23.53 percent increase over losses of $(0.17) per share
byMichael Horton
August 10, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.18) by 27.78 percent. This is a 23.53 percent increase over losses of $(0.17) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts